BRAF melanoma trang 1 tải miễn phí từ TAILIEUCHUNG

"BRAF melanoma" trang 1 - tải miễn phí từ Tailieuchung

A case report of a patient with metastatic ocular melanoma who experienced a response to treatment with the BRAF inhibitor vemurafenib

A case report of a patient with metastatic ocular melanoma who experienced a response to treatment with the BRAF inhibitor vemurafenib

5 52 1

Ifferential expression of ABCB5 in BRAF inhibitor-resistant melanoma cell lines

Ifferential expression of ABCB5 in BRAF inhibitor-resistant melanoma cell lines

10 127 1

Effect of dabrafenib on melanoma cell lines harbouring the BRAFV600D/R mutations

Effect of dabrafenib on melanoma cell lines harbouring the BRAFV600D/R mutations

3 30 1

Presence of immune cells, low tumor proliferation and wild type BRAF mutation status is associated with a favourable clinical outcome in stage III cutaneous melanoma

Presence of immune cells, low tumor proliferation and wild type BRAF mutation status is associated with a favourable clinical outcome in stage III cutaneous melanoma

9 36 1

Prolonged survival of a patient with metastatic leptomeningeal melanoma treated with BRAF inhibition-based therapy: A case report

Prolonged survival of a patient with metastatic leptomeningeal melanoma treated with BRAF inhibition-based therapy: A case report

5 30 1

The clinical response to vemurafenib in a patient with a rare BRAFV600DK601 del mutation-positive melanoma

The clinical response to vemurafenib in a patient with a rare BRAFV600DK601 del mutation-positive melanoma

8 71 1

Correlation between initial tumour volume and treatment duration on Dabrafenib: Observation study of subjects with BRAF mutant melanoma on the BRF112680 trial

Correlation between initial tumour volume and treatment duration on Dabrafenib: Observation study of subjects with BRAF mutant melanoma on the BRF112680 trial

8 39 0

Báo cáo hóa học:

Báo cáo hóa học: " Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032"

3 41 0

Ineffective anti PD-1 therapy after BRAF inhibitor failure in advanced melanoma

Ineffective anti PD-1 therapy after BRAF inhibitor failure in advanced melanoma

7 25 1

Prognostic significance of BRAF and NRAS mutations in melanoma: A German study from routine care

Prognostic significance of BRAF and NRAS mutations in melanoma: A German study from routine care

12 28 1

Next generation sequencing of exceptional responders with BRAF-mutant melanoma: Implications for sensitivity and resistance

Next generation sequencing of exceptional responders with BRAF-mutant melanoma: Implications for sensitivity and resistance

9 25 1

Comparison of high resolution melting analysis, pyrosequencing, next generation sequencing and immunohistochemistry to conventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAF mutations

Comparison of high resolution melting analysis, pyrosequencing, next generation sequencing and immunohistochemistry to conventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAF mutations

13 40 1

Cautious addition of targeted therapy to PD-1 inhibitors after initial progression of BRAF mutant metastatic melanoma on checkpoint inhibitor therapy

Cautious addition of targeted therapy to PD-1 inhibitors after initial progression of BRAF mutant metastatic melanoma on checkpoint inhibitor therapy

12 43 1

Comparative efficacy and safety of combination therapies for advanced melanoma: A network meta-analysis

Comparative efficacy and safety of combination therapies for advanced melanoma: A network meta-analysis

10 36 1

Is immunohistochemistry of BRAF V600E useful as a screening tool and during progression disease of melanoma patients?

Is immunohistochemistry of BRAF V600E useful as a screening tool and during progression disease of melanoma patients?

11 47 1

Case series: Indoor-photosensitivity caused by fluorescent lamps in patients treated with vemurafenib for metastatic melanoma

Case series: Indoor-photosensitivity caused by fluorescent lamps in patients treated with vemurafenib for metastatic melanoma

4 22 1

A combination of p300 and Braf expression in the diagnosis and prognosis of melanoma

A combination of p300 and Braf expression in the diagnosis and prognosis of melanoma

11 32 1

Severe pan-uveitis in a patient treated with vemurafenib for metastatic melanoma

Severe pan-uveitis in a patient treated with vemurafenib for metastatic melanoma

4 46 1

Risk factors for severe rash with use of vemurafenib alone or in combination with cobimetinib for advanced melanoma: Pooled analysis of clinical trials

Risk factors for severe rash with use of vemurafenib alone or in combination with cobimetinib for advanced melanoma: Pooled analysis of clinical trials

6 35 0

Inhibition of colony stimulating factor-1 receptor improves antitumor efficacy of BRAF inhibition

Inhibition of colony stimulating factor-1 receptor improves antitumor efficacy of BRAF inhibition

10 20 1

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.